GLP-1 medications are FDA-approved for chronic weight management in adults with a BMI of 30 or greater, or a BMI of 27 or greater alongside at least one weight-related condition, such as high blood pressure, Type 2 diabetes, or high cholesterol
Researchers in BMJ reviewed almost 10,000 reports of the use of weight loss medications or behavioral programs, and identified 37 studies with low risk of bias (with 9,431 participants) on which to perform a meta-analysis
Research shows that GLP-1 medications combined with lifestyle interventions produce stronger outcomes than medication alone
For rheumatoid arthritis, they are not replacements for your DMARD or biologic but the 2025 research from centers like UCLA suggests they can be a powerful complement: less disease activity, fewer flares, lower inflammation markers, better cholesterol and blood sugar, and reduced cardiovascular risk sometimes even at low doses
Acetyl L Carnitine is a highly bioavailable form of L-Carnitine, more easily absorbed from the gut and due to the presence of an acetyl group, is able to cross the blood brain barrier
Diabetes Rev